南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
南美超级胎牛血清999尝鲜特惠
转染试剂低至5折
基质胶阶梯特惠
积分商城,好礼送不停
分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

粘菌素复合纳米脂质体可有效治疗小鼠体内对粘菌素耐药的大肠杆菌感染。

Colistin compound nano-liposomes can effectively treat colistin-resistant Escherichia coli infections in mice

Li Shuai-hua, Zheng Ying-xu, Shao Hao-tian, Liu Pei-yi, Pan Yu-shan, Ma Xiao-yuan, Li Yuan, Zhai Ya-jun, Hu Gong-zheng

Journal:MATERIALS & DESIGN

IF:8.2

DOI:10.1016/j.matdes.2026.116961

PMID:

Published:2026-09-05

research field:代谢分子遗传学植物生物化学

Abstract

Oxyclozanide amine effectively reversed colistin resistance through a unique non-concentration-dependent dose–response relationship at low concentrations. • Colistin and oxyclozanide are co-encapsulated into nanoliposomes to address poor oral absorption and low water solubility. • The nanoliposomal formulation achieves prolonged intestinal retention and strong therapeutic efficacy against resistant Escherichia coli infection. • This study provides a promising oral antibacterial strategy for treating intestinal drug-resistant bacterial infections. Colistin (COL) is regarded as the last resort for treating infections caused by multidrug-resistant Gram-negative bacteria. However, there is currently a situation where colistin resistance is relatively high, resulting in poor treatment outcomes. In this study, colistin and oxyclozanide (OXY) were prepared into lipid nanoliposomes (COL-OXY@NPs) to address the aforementioned issues. We found that a low concentration of OXY can effectively reverse colistin resistance. FTIR shows a good binding between the drug and the lipid material. COL-OXY@NPs exhibits a distinct lipid structure. The particles are uniform and non-adherent, with a particle size of 170–240 nm, and the average size is 217.0 ± 4.2 nm, PDI in 0.05–0.2. Stability tests and simulated gastrointestinal fluid digestion proved that COL-OXY@NPs has good stability and acid and alkali resistance. In vitro and in vivo safety tests verified that COL-OXY@NPs has good biocompatibility. For multiple colistin-resistant Escherichia coli (E. coli) strains, COL-OXY@NPs significantly reduced the MIC of Free-COL (8 < MIC < 64) by 5–63 times. The fluorescence experiments on mice showed that COL-OXY@NPs have a long retention time in the intestinal tract, can significantly reduce the bacterial load in the intestinal tract and feces, and have a strong protective effect on the intestinal tissue structure. Schematic diagram of colistin and oxyclozanide co-loaded nano-liposomes and

本文使用的Yeasen产品

购物车
客服
转染试用